Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial. (nature.com)

Authors: Gay F … Broijl A Journal: Nature Medicine Published: 2026-05-01 DOI: https://doi.org/10.1038/s41591-026-04282-0